ArticleCell death & disease2025

mTORC2 inhibition reduces tumor burden via STAT1 activation and enhanced response to anti-PD-L1 therapy.

Anna Gschwendtner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.